Efficacy and safety of inclisiran in patients with established cerebrovascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised clinical trials

Authors: W Koenig, K K Ray, D G Kallend, U Landmesser, L A Leiter, G G Schwartz, R S Wright, L Garcia Conde, M Jaros, F J Raal

Published: 2021-10-20

DOI: 10.1093/eurheartj/ehab724.2026

Source: Full article


Abstract

Abstract